We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EUROPEAN GENERICS COULD FILE FOR FOLLOW-ON BIOLOGICS NEXT FALL
EUROPEAN GENERICS COULD FILE FOR FOLLOW-ON BIOLOGICS NEXT FALL
September 2, 2004
As the FDA prepares to hold its first discussion on the scientific issues surrounding follow-on biologics this month, European health officials are preparing a guidance that will let generic firms seek approval for biosimilar products as soon as next fall.